Gadoteridol Gadolinium Contrast from Canada
Paramagnetic gadolinium-based agent for MRI enhancement, functioning as an opacifying preparation for X-ray related imaging diagnostics. HTS 3006.30.5000 applies to this measured-dose vial for patient IV administration per chapter note 6(d).
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Certify NSF (nephrogenic systemic fibrosis) risk labeling per FDA
• Provide chelate stability data; ensure single-use vial integrity